Adaptive Biotechnologies Corpor

Historical 13F Holders

Symbol
ADPT
CUSIP
00650F109
All holders as of
Q4 2023
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q1 30 18.9 M $60.6 M
2023 Q4 205 144 M $708 M
2023 Q3 196 141 M $765 M
2023 Q2 215 136 M $915 M
2023 Q1 233 133 M $1.17 B
2022 Q4 233 135 M $1.03 B
2022 Q3 234 131 M $931 M
2022 Q2 219 134 M $1.08 B
2022 Q1 231 126 M $1.74 B
2021 Q4 222 124 M $3.48 B
2021 Q3 227 118 M $4.01 B
2021 Q2 241 118 M $4.81 B
2021 Q1 262 114 M $4.59 B
2020 Q4 268 114 M $6.76 B
2020 Q3 219 111 M $5.41 B
2020 Q2 212 101 M $4.89 B
2020 Q1 155 97.1 M $2.70 B
2019 Q4 141 86.5 M $2.59 B
2019 Q3 126 82.0 M $2.52 B
2019 Q2 113 78.2 M $3.74 B
2019 Q1 1 104 k $4.25 M
2016 Q3 1 235 $10.1 k